ME/CFS: what research says about fatigue that rest doesn’t fix

How ME/CFS is defined

For years, definitions of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) varied widely. In 2015 the US Institute of Medicine (IOM) proposed new diagnostic criteria in its report Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness, and the CDC points clinicians to them.

• A substantial reduction in the ability to engage in pre-illness levels of activity, lasting more than six months, with profound fatigue that is new, not the result of overexertion, and not substantially relieved by rest
• Post-exertional malaise (PEM): symptoms worsen after physical, mental or emotional exertion
• Unrefreshing sleep: not feeling better or less tired after a full night’s sleep
• Plus at least one of: cognitive impairment (problems with thinking, memory and information processing) or orthostatic intolerance (symptoms worsen on standing or staying upright)

Symptoms must be present at least half the time at moderate, substantial or severe intensity. ME/CFS, in other words, is defined not by tiredness alone but by a set of symptoms that occur together in a specific way.

Post-exertional malaise is the core

The feature that most clearly sets ME/CFS apart from other fatigue is post-exertional malaise (PEM). The CDC explains that symptoms can get worse after any activity, physical or mental. A routine shop or a stretch of focused work can be followed by a wave of fatigue, pain and cognitive symptoms.

That is why the usual rule that exercise builds fitness does not simply apply to ME/CFS.

Why it isn’t “just in the mind”

Because routine test results are often normal, ME/CFS has long been mistaken for malingering or a purely psychological problem. The CDC, however, describes it as a serious, often long-lasting illness that keeps people from their usual activities, and estimates that up to 3.3 million people in the US have it, more than nine in ten never diagnosed by a doctor.

But “not just mental” does not mean “cause found”. The studies below show measurable differences in the body; which are causes and which are consequences is not yet settled.

What research has found in the body

The NIH deep phenotyping study (2024)

The US National Institutes of Health recruited 17 people whose ME/CFS began after an infection, plus matched healthy volunteers, under strict criteria, and measured them extensively (blood, cerebrospinal fluid, muscle and stool, brain imaging, exercise and cognitive testing), publishing in Nature Communications in 2024. The team reported a change in “effort preference”, linked to dysfunction of integrative brain regions, as a defining feature, potentially associated with dysregulation of the brain’s catecholamine pathway, with knock-on effects on autonomic function and physical conditioning.

Immune profiling showed more naive B cells and fewer switched memory B cells, suggesting chronic antigen stimulation. Gene expression in blood immune cells and metabolic pathways also differed by sex. The paper states plainly that the pathophysiology is unknown and no disease-modifying treatment exists, and notes that 4 of the 17 participants recovered fully and spontaneously within four years. It is also a small study. See the brain.

An AI multi-omics study (Nature Medicine, 2025)

In 2025, researchers at the Jackson Laboratory and Duke University described BioMapAI in Nature Medicine: a deep learning model built on four years of follow-up data from 249 participants. Trained to predict symptom severity from gut metagenomics, plasma metabolomics, immune cell profiles, routine blood tests and clinical symptoms together, it classified ME/CFS in held-out data and in an independent external cohort. In patients, links between microbial metabolism (short-chain fatty acids, branched-chain amino acids, tryptophan), plasma lipids and bile acids were altered, and mucosal and inflammatory T cells such as MAIT and gamma-delta T cells showed heightened inflammatory responses.

The model is a research tool, not an established clinical diagnostic test.

A hypothesis about muscle

In a 2025 review, Carmen Scheibenbogen of Charité in Berlin and a co-author gathered an electron microscopy study showing damaged mitochondria in the skeletal muscle of people with ME/CFS, a study finding necrosis and regeneration side by side in muscle sampled the day after exercise, and an MRI study showing raised sodium inside muscle cells. The authors propose that sodium and subsequent calcium overload damage muscle and mitochondria. This is their hypothesis, and the paper discloses that one author runs a company developing an ME/CFS drug.

What is known about diagnosis and management

The UK’s National Institute for Health and Care Excellence (NICE) published its ME/CFS guideline (NG206) in October 2021. It recommends discussing energy management: planning and adjusting activity to stay within one’s energy limits, often called pacing. It is also clear that energy management is not a cure, but a self-management strategy led by the person with support from a specialist team.

• NICE advises against offering graded exercise therapy (fixed incremental increases in activity) or generalised exercise programmes to people with ME/CFS.
• NICE advises against offering any medicine or supplement to cure ME/CFS. Medicines for symptoms are a matter for a doctor, bearing in mind that people with ME/CFS may tolerate drugs less well.
• If fatigue has lasted more than six months, worsens after activity and isn’t relieved by sleep, seeing a doctor to rule out other causes and get a diagnosis is the first step.
• Sudden worsening or new symptoms should be checked separately rather than put down to ME/CFS.

This article is meant to help understanding of the illness. It does not replace diagnosis or treatment.